POMSnet helps cut production errors

By Gareth Macdonald

- Last updated on GMT

Related tags Pharmacology Manufacturing

US technology specialist Honeywell International says that new
features of its POMSnet manufacturing execution system (MES) can
help pharmaceutical firms reduce production errors.

The upgrade offers improved material handling capabilities that reduce the cycle-time of production runs, help cut down on errors and reduce compliance costs. In addition, a new batch rescaling tool, which features revised weighing and dispensing methods, can automatically adjust batch formulations during manufacture. The web-based POMSnet system is designed to help drugmakers expedite all aspects of manufacturing operations ranging from production to distribution and record keeping. Honeywell also believes that its system will improve the safety of trial participants because it features a centralised record keeping facility that can reduce response times during studies. "There truly is no room for error in pharmaceutical manufacturing, and technology is needed that can help drug makers produce the highest-quality products while maintaining plant safety and meeting very strict regulatory compliance,"​ said Ashish Gaikwad, global director for advanced solutions, at Honeywell's Process Solutions division. He added that "the new POMSnet upgrade was designed to run tighter processes while making the technology more user friendly. The new support for multiple languages enables customers worldwide to take advantage of this technology."​ "As more drug makers transition from paper systems to electronic records, reducing the effort needed to maintain inventory records can save up to $30,000 (€19,217) per clinical trial, which quickly adds up for companies that may execute as many as 200 trials per year​," said Gaikwad. Procedure Analyst ​ The system's POMStrace feature is designed to help improve the way in which clinical trial records are maintained. The system provides up-to-date information on supply levels, including patient distribution storing them in a central database. The platform can reduce potential risks to patients in case of a cancelled or recalled trial by blocking dispensing and providing immediate access to all logistical information. It also produces a traceability record of each patient kit and provides complete accounting for all materials for inclusion in regulatory submissions. The new upgrade is also compatible with Honeywell's Procedure Analyst software, which is designed to help drug manufacturers both manage and plan production runs and monitor supply chain performance.

Related news

Show more

Related products

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us

Products

View more

Webinars